Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive Mobile Health Smoking Cessation Intervention
NCT04020718Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nicotine in Tobacco Use Disorder (TUD) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Self-reported 7-day Abstinence From Smoking at 12 weeks. Started Jan 2020; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04020718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04020718.